Epithelial to Mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Pirozzi, Giuseppe ^a   Tirino, Virginia ^b   Camerlingo, Rosa ^a   Franco, Renato ^a   la Rocca, Aantonello ^a   Liguori, Eleonora ^a   Martucci, Nicola ^a   Paino, Francesca ^b   Normanno, Nicola ^a   Rocco, Gaetano ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; GLYCOPROTEIN; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; NANOG PROTEIN, HUMAN; PEPTIDE; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL GROWTH; CELL STRUCTURE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; RNA TRANSCRIPTION; TISSUE STRUCTURE; UPREGULATION; ANIMAL; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; TUMOR CELL LINE;

MUS;

ANIMALS; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; SOXB1 TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959735149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021548     Document Type: Article

References (47)

1. Clarke MF, Fuller M, (2006) Stem cells and cancer: two faces of eve. Cell 124: 1111-5.
2. Jordan CT, Guzman ML, Noble M, (2006) Cancer stem cells. N Engl J Med 355: 1253-61.
3. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-68.
4. Locke M, Heywood M, Fawell S, Mackenzie IC, (2005) Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65: 8944-50.
5. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, et al. (2011) Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. J Clin Invest 121: 384-95.
6. Jordan CT, (2004) Cancer stem cell biology: from leukemia to solid tumors. Curr Opin Cell Biol 16: 708-12.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-11.
8. D'Angelo RC, Wicha MS, (2010) Stem cells in normal development and cancer. Prog Mol Biol Transl Sci 95: 113-58.
9. Dean M, Fojo T, Bates S, Tumour stem cells and drug resistance. (2005) Nat Rev Cancer 5: 275-84.
10. Steinbach D, Legrand O, (2007) ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia 21: 1172-6.
11. Chuthapisith S, Eremin J, El-Sheemey M, Eremin O, (2010) Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol 19: 27-32.
12. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-8.
13. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-11.
14. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-14.
15. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, et al. (2009) The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg 36: 446-53.
16. Larue L, Bellacosa A, (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24: 7443-54.
17. Thiery JP, Chua K, Sim WJ, Huang R, (2010) Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma. Bull Cancer 97: 1285-95.
18. Hay ED, (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-20.
19. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, et al. (2011) Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 71: 245-54.
20. Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP, et al. (2001) IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20: 4942-50.
21. Thiery JP, (2001) Role of growth factor signaling in epithelial cell plasticity during development and in carcinogenesis. Bull Acad Natl Med 185: 1279-92.
22. Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Joven J, et al. (2010) Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle 9: 4461-8.
23. Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, et al. (2009) Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 28: 28.
24. Thiery JP, (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-6.
25. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, et al. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21: 759-806.
26. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-15.
27. Ju HK, Young SJ, Kwang-Seok E, Young IH, Hae RK, et al. (2007) Transforming Growth Factor β1 Induces Epithelial-to-Mesenchymal Transition of A549 Cells. J Korean Med Sci 22: 898-904.
28. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, et al. (2010) Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70: 338-46.
29. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-71.
30. Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, et al. (2007) p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 25: 807-15.
31. Wheelock MJ, Johnson KR, (2003) Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 15: 740-746.
32. Chaffer CL, Weinberg RA, (2011) A Perspective on Cancer Cell Metastasis. Science 331: 1559-1564.
33. Hayashida T, Jinno H, Kitagawa Y, Kitajima M, (2011) Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol 2011: 591427.
34. Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, et al. (2010) The Epithelial-Mesenchymal Transition Mediator S100A4 Maintains Cancer Initiating Cells in Head and Neck Cancers. Cancer Res 17 DOI:10.1158/0008-5472.
35. Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH, (2011) Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells. PLoS One 6: e16068.
36. Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, et al. (2005) Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11: 8686-98.
37. Tong M, Ding Y, Tai HH, (2006) Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Carcinogenesis 27: 2170-9.
38. Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z, (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 6: 56.
39. Lu Z, Ghosh S, Wang Z, Hunter T, (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515.
40. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, et al. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702.
41. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
42. Hida T, Ueda R, Sekido Y, Hibi K, Matsuda R, et al. (1994) Ectopic expression of c-kit in small-cell lung cancer. Int J Cancer Suppl 8 pp. 108-9.
43. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, et al. (2010) Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70: 338-46.
44. Levina V, Marrangoni AM, De Marco R, Gorelik E, Lokshin AE, (2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3: e3077.
45. Ferrandina G, Petrillo M, Bonanno G, Scambia G, (2009) Targeting CD133 antigen in cancer. Expert Opin Ther Targets 13: 823-37.
46. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A, (2008) Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarinomas. BMC Cancer 8: 1-14.
47. Bidlingmaier S, Zhu X, Liu B, (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86: 1025-32.